CIK 0001563880
- Non-accelerated filer
- Smaller reporting company
Trevi Therapeutics, Inc.
Sign in to watch- Ticker
- TRVI
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 450834299
- Phone
- +1 203-304-2499
- Business address
- 195 CHURCH STREET, 16TH FLOOR, NEW HAVEN, CT, 06510
- 4 Planned sale Chief Financial Officer sold 610 shares at $2.64 ($1,610)
- 4 Planned sale Chief Financial Officer sold 562 shares at $2.89 ($1,624)
- 4 Planned sale Chief Financial Officer sold 840 shares at $1.84 ($1,545)
- 4 Open-market sale Chief Financial Officer sold 892 shares at $1.75 ($1,564)
- 4 Exercise or conversion Chief Commercial Officer acquired 18,750 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Chief Financial Officer sold 8,474 shares at $2.45 ($20,761)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Former 10% Owner sold 500,000 shares at an average $2.89 ($1,444,012)
- 4/A Derivatives Options or other derivatives
- 4/A Derivatives Options or other derivatives
- 4/A Derivatives Options or other derivatives
Page 5 of 13 · 257 filings